polyurethane foam dress
DeviceApplication of the polyurethane foam dress at the heel in the immediate postoperative period before applied the Walker
NCT Number: NCT03039179
The post-operative treatment of pediatric patients operated for the correction of flat foot, sees today the use of preformed leg-foot splint (Walker) as an alternative to the application of plaster casts. The change of the immobilization system has led to the appearance of problems of tolerability in particular in the skin. The aim of the study is to assess whether by placing a polyurethane foam dress at the heel in the immediate postoperative period until removal of the Walker, the rate of skin lesion and pain is reduced.
Looking for future studies?
Notify Me3 year–18 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Application of the polyurethane foam dress at the heel in the immediate postoperative period before applied the Walker
Time frame: every day until discharge (expected average of 3 days)
Numbers of Participants With Heel Pressure Sores of all grade Detected According to the Classification of the Scale of the National Pressure Ulcer Advisory Panel -N.P.U.A.P.: Grade 1: Non-blanchable erythema of intact skin. Discoloration of the skin, warmth, oedema, induration or hardness may also be used as indicators, particularly in individuals with darker skin. Grade 2: Partial thickness skin loss involving epidermis, dermis, or both. The ulcer is superficial and presents clinically as an abrasion or blister. Grade 3: Full thickness skin loss involving damage to or necrosis of subcutaneous tissue that may extend down to, but not through, underlying fascia. Grade 4: Extensive destruction, tissue necrosis, or damage to muscle, bone, or supporting structures with or without full thickness skin loss.
Time frame: up to the first 3 days post intervention
Pain Score on the "Numeric Rating Scale" > 3. The scale had values from 0 to 10 where zero represented no pain and 10 the worst possible pain. More than 3 means pain.
Istituto Ortopedico Rizzoli
Other
Effectiveness of Polyurethane Foam in Preventing the Onset of Pressure Sores in a Pediatric Orthopedic Population: Randomized Controlled Trial
Acronym: SCHIUMABIMB
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07681635
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Islamabad, Federal, Pakistan
View Trial DetailsNCT03918798
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Bari, Italy
View Trial DetailsNCT06045208
Behavior, Congenital Abnormalities
Bahçelievler, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06499545
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
San Sebastián de los Reyes, Madrid, Spain
View Trial Details